Yahoo Web Search

Search results

1. • Multicancer early detection tests for cancer diagnosis

     Medical Xpress· 4 days ago

     Cancer is characterized by the uncontrolled proliferation and spread of abnormal cells within the body. Malignant tumors, unlike benign ones, invade nearby tissues and spread ...

2. • ...of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer - Puma...

     Benzinga· 15 hours ago

     Puma Biotechnology, Inc. PBYI, a biopharmaceutical company, announced the presentation of alisertib for the treatment of patients with advanced osimertinib-resistant epidermal growth factor ...

3. • 

     Study reveals that gastric cancer surgery may reduce heart disease risk

     Medical Xpress· 5 days ago

     Gastric cancer, also known as stomach cancer, is a highly prevalent and aggressive form of the...

4. • 

     Cancer Care: Tips for Getting All Your Questions Answered

     Healthline· 4 days ago

     Asking for a detailed explanation of your diagnosis is important because it helps you understand the...

5. • Improved Outcomes With Subcutaneous Amivantamab in NSCLC

     Medscape· 2 days ago

     Subcutaneous amivantamab plus lazertinib may offer a survival benefit over intravenous administration, alongside dramatically reduced administration times, a new study suggests.

6. • Colon cancer rates are rising in young Americans, but insurance barriers are making screening harder

     Stamford Advocate· 6 days ago

     Although colorectal cancer is the second-most common cause of cancer deaths in the United States, it can be cured if caught early. With the alarming rise ...

7. • 'An extension on life:' Madison survivor shares clinical trial experience during Uterine Cancer...

     CBS 58 Milwaukee· 12 hours ago

     MADISON, Wis. (CBS 58) -- It's a beautiful, sunny day in Madison and Judi Trampf and her wife are out gardening."Can you get to one behind there?" Trampf asks, as she hands over a watering can.Both are smiling and

8. • Bio-Thera Solutions Presents Clinical Data for BAT8006 (Folate Receptor-alpha-ADC) at the 2024...

     Benzinga· 2 days ago

     GUANGZHOU, China, June 2, 2024 /PRNewswire/ -- Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, will present a poster at

9. • Small Business - The Andalusia Star-News | The Andalusia Star-News

     The Andalusia Star-News· 6 hours ago

     RemeGen Reports Proof-of-Concept Phase I/II Clinical Study Results for Self-Developed, Potential First-in-Class Antibody-Drug Conjugate RC88 PR Newswire YANTAI, China, June 3, 2024 YANTAI, China, June 3, 2024 /PRNewswire/ -- RemeGen Co., Ltd. ("

10. • 

      Carefully Designing De-escalation Trials in Breast Cancer

      Medscape· 5 days ago

      De-escalation trials in early breast cancer are "critical to preserving quality of life" but require...